Biotech

All Articles

Vertex, hammered through AATD again, falls 2 resources on dispose of stack

.Vertex's try to manage an uncommon hereditary illness has actually reached yet another trouble. The...

Vir gains 3 T-cell engagers from Sanofi, gives up 25% of workers

.Vir Biotechnology's second-quarter revenues file had not been except large information. The company...

Galapagos stops CAR-T cell therapy trial over Parkinsonism case

.Galapagos has stopped application in a trial of a BCMA-directed CAR-T cell treatment, pumping the b...

James Wilson leaving Penn to launch pair of brand-new biotechs

.After greater than 30 years, genetics treatment innovator James Wilson M.D., Ph.D., is leaving behi...

3 biotechs attempt to trump the summer months heat by shedding staff

.As biotechs seek to turn a fresh page in August, at the very least 3 providers have lost staff in e...

venBio raises $528M for fifth lifestyle scientific researches VC fund

.Veteran venture capital firm venBio has raised one more half a billion dollars to purchase biotechs...

Otsuka spends $800M for Jnana and also its own clinical-stage PKU medication

.Otsuka Pharmaceutical has grabbed Boston-based Jnana Therapeutics for $800 million so the Japanese ...

FibroGen gives up 75% people team as asset flunks 2 more trials

.FibroGen is actually drastically restructuring its company, giving up 75% of its USA personnel and ...

Tracon unwind weeks after injectable PD-L1 inhibitor stop working

.Tracon Pharmaceuticals has actually determined to relax functions weeks after an injectable invulne...

Ideaya bags option on Biocytogen bispecific ADC in $400M offer

.Ideaya Biosciences is wagering $400 thousand in biobucks that a bispecific antibody-drug conjugate ...